Communicating with patients with nAMD and their families during the COVID-19 pandemic.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. The Effects of the COVID-19 Pandemic on the Follow-Up of Patients with Age-Related Macular Degeneration in a Tertiary Hospital in London, the UK.Journal of clinical medicine · 2025
   Article
2. The effect of COVID-19 pandemic restrictions on neovascular AMD patients treated with treat-and-extend protocol.International ophthalmology · 2021
   Article
3. Assessment of Patients' Confidence Regarding a New Triage Concept in a Medical Retina Clinic during the First COVID-19 Outbreak.International journal of environmental research and public health · 2021
   Article
4. Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2021
   Article
5. A Year of Living Dangerously: Challenges and Recommendations for Safely Performing Ophthalmic Surgery During the COVID-19 Pandemic, from Start to Finish.Clinical ophthalmology (Auckland, N.Z.) · 2021
   Review
6. The influence of delayed treatment due to COVID-19 on patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.Therapeutic advances in chronic disease · 2021
   Article
7. Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2020
   Review

Corrections and comments

• Comment on
  Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic.2020

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as